China COVID-19 Diagnostics Market Trends, Size, Competitive Analysis and Forecast 2020-2026

China COVID-19 diagnostics market will see declined growth of 25.1% during the forecast period. China has a significant market share in the global COVID-19 diagnostic market owing to the growing number of diagnostic screening in the country coupled with government initiatives for providing rapid screening for COVID-19. Moreover, the introduction of advanced and early diagnostic tests in the country further propels the growth of the market. For instance, in February 2020, the Government of China opened a 2,000 square-meter emergency detection laboratory called Huoyan in Wuhan City which can process over 10,000 samples a day.

Request a Free Sample of our China COVID-19 Diagnostics Market: https://www.omrglobal.com/request-sample/china-covid-19-diagnostics-market

In April 2020, Sansure Biotech, Inc. developed a fast COVID-19 nucleic acid testing system and approved by the NMPA that does not require a professional laboratory and gives a test result within 15-45 minutes. The Novel Coronavirus (2019-nCoV) Nucleic Acid Diagnostic Kit (PCR-Fluorescence Probing) is a real-time reverse transcription-polymerase chain reaction (rRT-PCR) test. The 2019-nCoV primer and probe set(s) is designed to detect RNA from SARS-CoV-2 in respiratory specimens from patients with signs and symptoms of infection who are suspected of COVID-19. Therefore, these advancements in the diagnostics kit for COVID-19 further provide significant growth in the market.

A full Report of China COVID-19 Diagnostics Market is Available at: https://www.omrglobal.com/industry-reports/china-covid-19-diagnostics-market

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID -19
o Most affected segment
o Recommendations
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

China COVID-19 Diagnostics Market – Segmentation

By Type

• Instruments
• Reagents & Kits
• Laboratory Testing Services

By Technology Type

• PCR Test
• Antigen Test
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
• Serology Test
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
• Rapid/ PoC Test

By Sample Type

• Oropharyngeal & Nasopharyngeal Swabs
• Blood
• Urine
• Saliva
• Others (Sperm)

By End-Users

• Laboratories
• Hospitals
• Diagnostic Centers & Clinics
• Research Institutes

Company Profiles

• Anbio (Xiamen) Biotechnology Co., Ltd.
• Beijing Applied Biological Technologies Co., Ltd.
• BGI Group
• Chengdu CapitalBio Biotechnology Co., Ltd.
• Da An Gene Co., Ltd.
• Guangzhou Wondfo Biotech Co., Ltd.
• Maccura Biotechnology Co., Ltd.
• Sansure Biotech, Inc.
• Shanghai BioGerm Medical Biotechnology Co., Ltd
• Ustar Biotechnologies (Hangzhou), Ltd.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/china-covid-19-diagnostics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.